27 March 2020
Countrys: World and Kenya, Zambia, Ethiopia
The restrictions on movement imposed as a result of the COVID-19 pandemic constitute one of the largest single global challenges that the humanitarian community has ever encountered. Maintaining continuity and quality in the delivery of e...ssential assistance and services, including protection services, in the face of these restrictions requires operations to quickly innovate, leveraging fully the rich capacities and established networks within both communities of persons of concern, as well as host communities.
more
Early Identification and Early Intervention Services for Young Children with Developmental Delays and Disabilities in Namibia Republic of Namibia Namibia
Regional Consultations Report
Two malaria vaccines are currently WHO prequalified and recommended1 for use to prevent
P. falciparum malaria in young children, the RTS,S/AS01 vaccine, currently manufactured by
GlaxoSmithKline (GSK), and the R21/Matrix-M vaccine, manufactured by Serum Institute of India
Pvt (SII)
This guidance covers different options for banning or phasing out a pesticide and suggests related risk reduction measures to be taken during the phase-out period. A key focus of this guidance is how to take action to manage, prevent, minimize, and communicate about identified risks during the imple...mentation of a phase-out strategy. It contains a description of legal aspects to consider when phasing out a product and illustrates how a risk communication plan can be structured and implemented. How different stakeholders may be involved when a pesticide is going to be phased out is also described.
more
Accessed June 2025. This document outlines the Ministry of Health's management guidelines for malaria in pregnancy in Uganda. Pregnant women without malaria symptoms receive intermittent preventive treatment in pregnancy (IPTp) using sulfadoxine-pyrimethamine (SP) as directly observed therapy (DOT),... starting from the second trimester with monthly doses until delivery, except for HIV-positive mothers on cotrimoxazole.
more
En el año 2020 se registró una muerte materna cada hora en América Latina y el Caribe (ALC). Ese mismo año, la tendencia de la razón de mortalidad materna (RMM) en la Región de las Américas retrocedió de manera alarmante e inaudita a los niveles de hace veinte años. Estas cifras no solo imp...lican un empeoramiento en los resultados, sino una profundización de las desigualdades, lo que representa miles de tragedias individuales e inaceptables que en la mayoría de los casos serían evitables. La muerte materna es el resultado de un proceso multifactorial donde interactúan elementos estructurales como el sistema económico, las condiciones ambientales y la cultura. Además, intervienen otros factores relativos a la desigualdad social, como el racismo, la pobreza, la desigualdad de género y la falta de acceso al sistema educativo
more
Shown in blue is the estimated annual number of deaths attributed to drug use. Shown in red is theestimated annual number of deaths from drug use disorders. The difference between them is that theyrelate to indirect and direct causes of death, respectively.
En el año 2020 se registró una muerte materna cada hora en América Latina y el Caribe (ALC). Ese mismo año, la tendencia de la razón de mortalidad materna (RMM) en la Región de las Américas retrocedió de manera alarmante e inaudita a los niveles de hace veinte años. Estas cifras no solo imp...lican un empeoramiento en los resultados, sino una profundización de las desigualdades, lo que representa miles de tragedias individuales e inaceptables que en la mayoría de los casos serían evitables. La muerte materna es el resultado de un proceso multifactorial donde interactúan elementos estructurales como el sistema económico, las condiciones ambientales y la cultura. Además, intervienen otros factores relativos a la desigualdad social, como el racismo, la pobreza, la desigualdad de género y la falta de acceso al sistema educativo
more
Estimated annual number of deaths from drug use disorders, by type of drug.
Diabetes poses an increasingly serious health challenge in Africa. Currently, 25 million adults aged 20–79 are living with diabetes, and this figure is projected to increase by 142% to 60 million by 2050 — the highest regional increase worldwide. However, 73% of cases remain undiagnosed, and hea...lthcare spending is the lowest worldwide at just USD 10 billion (1% of global expenditure). In 2024, diabetes caused 216,000 deaths and had a significant impact on maternal health, affecting 1 in 7 births due to hyperglycaemia during pregnancy. Nigeria, Tanzania and the Democratic Republic of the Congo have the highest case loads. Without urgent intervention, the diabetes burden will continue to grow, putting further strain on already limited health systems.
more